
Atara Biotherapeutics ATRA
€ 4.36
-6.12%
Quartalsbericht 2025-Q3
hinzugefügt 12.11.2025
Atara Biotherapeutics Langfristiger Schuldenstrom 2011-2026 | ATRA
Langfristiger Schuldenstrom Jährlich Atara Biotherapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.9 M | 11.3 M | 12.8 M | 2.58 M | 1.73 M | 1.31 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 12.9 M | 1.31 M | 7.1 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
1.1 M | $ 15.94 | -3.66 % | $ 3.8 B | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.51 | -3.31 % | $ 1.05 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.84 | 1.57 % | $ 4.58 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
7.09 M | $ 20.16 | 1.51 % | $ 2.54 B | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.8 M | $ 75.6 | -1.22 % | $ 1.46 B | ||
|
Applied Therapeutics
APLT
|
429 K | - | - | $ 8.42 M | ||
|
Autolus Therapeutics plc
AUTL
|
5.05 M | $ 1.49 | -8.59 % | $ 380 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
434 K | $ 162.3 | -1.08 % | $ 8.07 B | ||
|
BridgeBio Pharma
BBIO
|
6.19 M | $ 65.02 | -2.29 % | $ 12.5 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
549 K | - | -2.5 % | $ 5.88 M | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
20.7 M | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
3.29 M | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
203 K | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
522 K | $ 2.77 | -1.42 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
8.57 M | $ 60.51 | 0.13 % | $ 11.6 B | ||
|
Equillium
EQ
|
440 K | $ 1.75 | - | $ 60.8 M | ||
|
Cabaletta Bio
CABA
|
3.56 M | $ 3.21 | -6.52 % | $ 3.75 M | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
2.59 M | $ 3.01 | -5.94 % | $ 1.08 M | ||
|
Ayala Pharmaceuticals
AYLA
|
419 K | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
749 K | $ 25.27 | -0.9 % | $ 677 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
1.08 M | $ 34.25 | -4.03 % | $ 3.56 B |